‍

Dear Foregen Supporters,

‍

In February, we made significant strides in advancing our research project. Here are some highlights of our progress:

‍

Sheep Trials Begin

The latest round of sheep trials commenced on February 12th, 2024. Dr. Palumbo and her team are testing a method of partially burying foreskin ECMs under the sheep’s skin to measure vascularization. The goal is to determine if the tissue can be adequately prepared for successful integration, without vascularity issues, when applied in human surgeries. Your incredible support during our recent GoFundMe campaign made this possible!

‍

Outside Consultations

Foregen continues to liaise with additional surgeons, scientists, and professionals to seek further consultations and explore new research partnerships. Our recent meeting with Dr. Dan mon O’Dey focused on our approach to surgery in upcoming human clinical trials. We will keep the community informed on the progress of these efforts.

‍

Potential Collaborations

To meet potential future demand, we understand the need to develop new solutions for challenges such as tissue sourcing, clinical and surgical partnerships, and ECM production technologies. We are actively exploring potential collaborations with capable institutions and will provide updates as developments occur.

‍

Clinical Research Manager

We have initiated the recruitment of a Clinical Research Manager. This role is crucial for coordinating all our research activities and progressing efficiently towards our goal of successfully completing human clinical trials. Their expertise will be key in navigating the complexities of clinical research and accelerating our path to success.

‍

Fundraising

Thanks to our incredibly generous and supportive community, Foregen raised a total of $23,626 in February! These funds enable us to secure laboratory space, materials, and staff necessary for our research. We are deeply grateful for your support.

Your continued support can make a significant difference. Join us in developing the world’s first regenerative medicine solution for circumcised men.

‍

Sincerely,

‍

Ryan Jones

Chief Operations Officer

‍